In a market where dividend cuts have become as common as earnings disappointments, one healthcare giant stands as an unshakeable fortress: Johnson & Johnson (NYSE: JNJ). While other “dividend aristocrats” have stumbled and fallen during recent economic turbulence, JNJ has quietly achieved something that borders on the miraculous in today’s volatile market—64 consecutive years of dividend increases.

This isn’t just impressive; it’s historically unprecedented. To put this achievement in perspective, JNJ has increased its dividend yearly since 1961. That means this company has never once failed to reward shareholders with a higher payout through the Vietnam War, the oil crises of the 1970s, Black Monday in 1987, the dot-com crash, the 2008 financial crisis, and the COVID-19 pandemic. In the dividend investing community, this track record doesn’t just earn respect—it commands reverence.